Krista L Lanctôt, Luc Rivet, Shankar Tumati, Jamie Perin, Krushnaa Sankhe, Danielle Vieira, Jacobo Mintzer, Paul B Rosenberg, David Shade, Alan J Lerner, Prasad R Padala, Olga Brawman-Mintzer, Christopher H van Dyck, Anton P Porsteinsson, Suzanne Craft, Allan I Levey, Kalpana P Padala, Nathan Herrmann
OBJECTIVE: The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) found that methylphenidate was effective in treating apathy with a small-to-medium effect size but showed heterogeneity in response. We assessed clinical predictors of response to help determine individual likelihood of treatment benefit from methylphenidate. DESIGN: Univariate and multivariate analyses of 22 clinical predictors of response chosen a priori. SETTING: Data from the ADMET 2 randomized, placebo controlled multi-center clinical trial...
June 15, 2023: American Journal of Geriatric Psychiatry